New Zealand firm Greenfern Industries has attained Good Agriculture and Collection Practice (GACP) certification for its Taranaki cultivation facility as it gears up to export medicinal cannabis.

Greenfern managing director Dan Casey

Citing a Ministry of Foreign Affairs and Trade report that the average farm gate price for medicinal cannabis in Germany, one of Europe’s largest markets, will be €2.20/g or NZ$3.65, managing director Dan Casey said Greenfern could grow, dry, and package product at a much lower cost than that.

“Having our own hydroelectric power station and utilising power at cost price helps keep the cultivation costs to a minimum,” he said. “Electricity costs make up a large portion of your operating expenditure when growing cannabis in a fully enclosed indoor environment, [so] this is a real long-term strategic benefit for Greenfern. We are excited to scale up our stage two facility in the near future.”

“Our GACP certification should help progress further talks and secure binding offtake contracts with overseas buyers for our medicinal cannabis grown right here in Taranaki,” he added.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...